MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Association of Parkinson’s disease with essential tremor

    D. Aygun (Samsun, Turkey)

    Objective: In this study we present the clinical characteristics of 10 patients (6 males, 4 females) with both essential tremor (ET) and Parkinson's disease (PD).…
  • 2016 International Congress

    Clinical and biological predictors of time to initiation of symptomatic therapy in early Parkinson’s disease

    T. Simuni, J. Long, C. Caspell-Garcia, C.S. Coffey, S. Lasch, C. Tanner, D. Jennings, K. Kieburtz, K. Marek, On behalf of the PPMI Investigators (Chicago, IL, USA)

    Objective: To determine clinical and biological variables that predict time to initiation of symptomatic therapy (TIST) in de novo Parkinson's disease (PD) patients. Background: There…
  • 2016 International Congress

    ADS-5102 (amantadine HCl) extended-release capsules reduced levodopa-induced dyskinesia in the phase 3 EASE LID study

    R. Pahwa, C.M. Tanner, R.A. Hauser, P. Nausieda, D.D. Truong, K. Hull, P. Agarwal, R. Johnson, A.E. Ruby, N.L. McClure, M.J. Stempien (Kansas City, KS, USA)

    Objective: To investigate the efficacy and safety of ADS-5102 (amantadine HCl) extended release capsules 340 mg daily at bedtime for the treatment of levodopa-induced dyskinesia…
  • 2016 International Congress

    Peripheral neuropathies in Parkinson’s disease during levodopa-carbidopa intestinal gel treatment: Results from a long-term prospective follow-up study

    A. Romagnolo, A. Merola, M. Zibetti, A. Bernardini, D. Cocito, C.A. Artusi, F. Dematteis, S. Angrisano, M.G. Rizzone, L. Lopiano (Turin, Italy)

    Objective: To prospectively evaluate, in a cohort of Parkinson's disease (PD) patients, the incidence of peripheral neuropathies (PNP) during Levodopa/Carbidopa intestinal gel (LCIG) treatment. Background:…
  • 2016 International Congress

    Reflex saccades changes can estimate long-term symptom progression in DBS STN and MED Parkinson’s disease patients (PD)

    S. Szlufik, A. Przybyszewski, J. Dutkiewicz, P. Habela, T. Mandat, D. Koziorowski (Warsaw, Poland)

    Objective: The aim of this study was to evaluate the impact of STN DBS on RS parameters in PD. We have compared disease progression in…
  • 2016 International Congress

    Improvement in posture, pain, and cardiac autonomic function in a prospective study of osteopathic manipulative medicine and physical therapy for camptocormia in Parkinson’s disease

    J.D. Mancini, D.M. Pasternack, N. Caruana, A. Leder (Old Westbury, NY, USA)

    Objective: A prospective cohort study of the effectiveness of osteopathic manipulative medicine (OMM) and physical therapy in improving postural control and dysautonomia in Parkinson's disease…
  • 2016 International Congress

    Changes of speech after neurostimulation for Parkinson’s disease with early fluctuations: A 2-years randomized controlled trial (earlystim-speech)

    S. Pinto, A. Nebel, R. Espesser, J. Rau, P. Maillochon, O. Krack, K. Knudsen, A. Ghio, O. Niebuhr, Y. Agid, M. Schüpbach, G. Deuschl (Aix-en-Provence, France)

    Objective: To assess the effect of subthalamic deep brain stimulation (STN-DBS) on speech in Parkinson's disease patients with early fluctuations and dyskinesia. Background: The effect…
  • 2016 International Congress

    Effect of right DLPFC-repetitive transcranial magnetic stimulation (rTMS) on tardive dyskinesia in patients with psychosis

    S. Lavania, A. Pattojoshi, A.H. Khan, S. Lavania (Agra, India)

    Objective: The index study was done to examine any change in tardive dyskinesia, cognitive function and psychopathology following high frequency rTMS of the right Dorsolateral…
  • 2016 International Congress

    Are Parkinson’s disease futility studies futile?

    B.C. Tilley, J. Elm (Houston, TX, USA)

    Objective: Revisit Phase II futility studies. Background: Published results of a Phase III trial of creatine monohydrate for Parkinson's disease (PD) in the presence of…
  • 2016 International Congress

    DBS related on-state freezing of gait – A case series

    Y.C. Tai, E. Everingham, D. Tsui, V. Fung, N. Mahant (Kaohsiung, Taiwan)

    Objective: To present the first ever case series of on-state freezing of gait (FOG) after DBS surgery using dose-cycle gait evaluation. Background: FOG is categorized…
  • « Previous Page
  • 1
  • …
  • 205
  • 206
  • 207

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley